This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide the drug ESBRIET 801 MG TABLET 90S. The $3,311.50 firm-fixed-price delivery order has a completion date of November 13, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs. This particular delivery order does not have a set-aside designation, indicating open competition. The award demonstrates AmerisourceBergen's role as a critical vendor for federal healthcare agencies, supplying essential medical commodities across various therapeutic areas.
Generated 1/22/25, 12:51 AM